ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Wednesday, 18 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Regulatory Approval

Bhageria Industries Regulatory Approval

Bhageria Industries received EDQM attestation of GMP inspection for its Vapi facility, confirming EU GMP compliance for Dexamethasone under CEP No. 2024-138. No monetary value is disclosed.

Source

BSE filing, NSE: BHAGERIA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bhageria Industries Ltd: key numbers

Share price
₹364.80
Market cap
₹1,592 Cr
Revenue (annual)
₹874.0 Cr
Net profit (annual)
₹46.08 Cr
P/E (TTM)
14.1×Sector 26.4×
Promoter holding
71.85%+0.08% QoQ
FII holding
0.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bhageria Industries Ltd

All →
18:33 IST BSE
Financial Results

Bhageria Industries Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 384.3% YoY

Bhageria Industries Ltd reported revenue from operations of ₹455.7 Cr (+122.9% YoY) and net profit of ₹55.7 Cr (+384.3% YoY) for Q2 FY27.

Key figure
Net profit ₹55.7 Cr · +384.3% YoY

Other regulatory approval announcements

All →
22:22 IST BSE
Regulatory ApprovalSenores Pharmaceuticals Ltd SENORES

Senores Pharmaceuticals Regulatory Approval

Senores Pharmaceuticals disclosed that its subsidiary Ratnatris Pharmaceuticals' Mehsana facility received PIC/S GMP certification from Ukraine's SMDC. The certificate, issued 16 November 2026, opens a wider pathway to regulatory approvals.

22:48 IST BSE
Regulatory ApprovalXtglobal Infotech Ltd XTGLOBAL

Xtglobal Infotech Regulatory Approval

XTGlobal received RBI approval for a ₹0.10 Crore (EUR 10,000) equity investment in its Irish subsidiary. The initial capital supports its European expansion plans.

Value
₹0.10 Cr
08:36 IST BSE
Regulatory ApprovalBiocon Ltd BIOCON

Biocon Regulatory Approval

Biocon received U.S. FDA approval for Pebrilzo (pertuzumab-qcay), a biosimilar to Perjeta, its fifth oncology biosimilar approved in the US. A global settlement with Genentech sets the earliest US launch in Q3 2028.

21:03 IST BSE
Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTD

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Binimetinib tablets, securing 180 days of generic drug exclusivity for the product.

19:00 IST BSE
Regulatory ApprovalUnited Breweries Ltd UBL

United Breweries Regulatory Approval

United Breweries received BIADA's final order restoring its 42-acre Patna land allotment under the Amnesty Policy 2025, subject to conditions. Commercial production milestones must be met within 24 months.